Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous recombinant human brain natriuretic peptide adjunct to primary PCI in STEMI
ChiCTR-TRC-08000070Phase 4Completed
- Sponsor
- Renji Hospital
- Start
- Apr 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nesiritide in myocardial infarction (MI) (2 arms), sponsored by Renji Hospital. Primary endpoints: Wall motion score index in echocardiography and TIMI myocardial perfusion grade. Started Apr 2008; status: completed.
02
Drugs
nesiritide
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR-TRC-08000070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000070.